Want the latest recommendations from zacks investment research? On average, they expect opgen's share price to reach $5.50 in the next twelve months.
Is currently rated as a zacks rank 3 and we are expecting an inline return from the opgn shares relative to the market in the next few months.
Opgn stock forecast zacks. The average price target represents a 248.10% upside from the last price of $1.58. The company has topped consensus revenue estimates two times over the last four quarters. (opgn) stock quote, history, news and other vital information to help you with your stock trading and investing.
Opgen has not formally confirmed its next earnings publication date, but the company's estimated earnings date is thursday, march 24th, 2022 based. (opgn) came out with a quarterly loss of $0.29 per share versus the zacks consensus estimate of a loss of $0.22. Fbi provides new details on deadly pentagon attack.
Wall street stock market & finance report, prediction for the future: Free stock analysis report to read this article on zacks.com click here. Opgen inc () stock market info recommendations:
Click to get this free report opgen, inc. Opgen has generated ($1.19) earnings per share over the last year ( ($1.19) diluted earnings per share). (opgn) came out with a quarterly loss of $0.19 per share in line with the zacks consensus estimate.
Opgen, inc.which belongs to the zacks medical services industry, posted revenues of $1.35 million for the quarter ended december 2020, surpassing the zacks consensus estimate by 4%. 8:00a datadog stock rallies after results, outlook exceed wall street expectations Click to get this free report opgen, inc.
The average price target is $5.50, with a high forecast of $7.00 and a low forecast of $4.00. This chart shows the closing price for opgn for the last year in relation to the current analyst high, average, and low pricetarget. Today, you can download 7 best stocks for the next 30 days.
By zacks equity research published on march 25,2021. Nonfarm payrolls estimated to rise 450,000 in october. You'll find the opgen share forecasts, stock quote and buy / sell signals below.according to present data opgen's opgn shares and potentially its market environment have been in bearish cycle last 12 months (if exists).
However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release. The company utilizes molecular diagnostics and informatics to help combat infectious diseases. Zacks' proprietary data indicates that opgen, inc.
Earnings for opgen are expected to grow in the coming year, from ($0.85) to ($0.60) per share. This suggests a possible upside of 271.6% from the stock's current price. Want the latest recommendations from zacks investment research?
Data coming in 30 minutes. Opgen, inc., a precision medicine company, engages in developing molecular information products and services in the united states and internationally. Their forecasts range from $4.00 to $7.00.
(opgn) delivered earnings and revenue surprises of. Today, you can download 7 best stocks for the next 30 days. In terms of the zacks industry rank, medical services is currently in the bottom 29% of the 250 plus zacks industries.
Find the latest opgen, inc. 60% of americans think it. (opgn) may report negative earnings:
Know the trend ahead of q2 release. Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. It also helps clinicians with information about life threatening infections, enhance.
Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. This compares to loss of $0.49 per share a year ago. Buy or sell opgen stock?
(opgn) reports q4 loss, tops revenue estimates.
0 komentar:
Posting Komentar